---

Moringa oleifera leaf extract ameliorates cisplatin evoked neurotoxicity in male wistar rats

Full Text PDF Share on Facebook Share on Twitter

---

Original Article

Author Details : Sanjiv Karale*, Mohammed Farshad P, Jagadish V Kamath

Volume : 8, Issue : 1, Year : 2023

Article Page : 54-58

https://doi.org/10.18231/j.ijcaap.2023.009

Suggest article by email

Get Permission

Abstract

The study was intended to explore the potential role of Moringa oleifera leaf extract (MOLE) on cisplatin (CIS) induced neuronal damage in experimental male rats. In the current work, animals were divided into four groups, six animals in each group. Group-1 (Normal) administered with Distilled water 1ml p.o. Group-2 (CIS) was received cisplatin 5mg/kg, ip. single dose. Group-3 (CIS + MOLE 200mg/kg) was orally administrated MOLE 200mg/kg, dissolved in water for 14 days with a cisplatin 5 mg/kg, ip. single dose on 10 day. and Group-4 (CIS + MOLE 400mg/kg) was orally administrated MOLE 400mg/kg, dissolved in water for 14 days with a cisplatin 5mg/kg, ip. single dose on 10 day. After 14 days of MOLE dosing, the rats were sacrificed after anesthetizing with ketamine. Brain of individual rat was excised and processed for evaluation of oxidative injury markers like malonyl dialdehyde (MDA), glutathione (GSH), superoxide dismutase (SOD), catalase and histopathological study. MOLE treated experimental groups explored a potential (P<0>  

Keywords: Cisplatin, Oxidative stress, Neurodegeneration, Moringa oleifera leaf extract, Neuroprotective, Antioxidants, Histopathology

How to cite : Karale S, Mohammed Farshad P, Kamath J V, Moringa oleifera leaf extract ameliorates cisplatin evoked neurotoxicity in male wistar rats. IP Int J Compr Adv Pharmacol 2023;8(1):54-58

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.